Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation

Institut Claudius Regaud · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
nsclc
nsclc, anti-pd-l1, durvalumab, stereotactic radiation therapy, oligometastatic disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 880671
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.